ACADIAN ASSET MANAGEMENT LLC - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 45 filers reported holding LUMOS PHARMA INC in Q2 2020. The put-call ratio across all filers is 5.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q2 2021$22,000
-68.1%
2,186
-62.8%
0.00%
Q1 2021$69,000
-45.7%
5,879
+65.0%
0.00%
Q4 2020$127,000
+78.9%
3,564
-30.9%
0.00%
Q3 2020$71,000
-88.0%
5,161
-85.7%
0.00%
-100.0%
Q2 2020$594,00036,0450.00%
Other shareholders
LUMOS PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Minerva Advisors LLC 34,015$321,0000.21%
Lion Point Capital, LP 51,205$481,0000.11%
Wealth Advisors of Iowa, LLC 11,699$110,0000.06%
NEA Management Company, LLC 167,608$1,575,0000.04%
Paladin Advisory Group, LLC 4,382$40,0000.03%
Marquette Asset Management, LLC 13,315$125,0000.03%
Blackstone Inc. 468,145$4,401,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$450,0000.01%
Jefferies Group LLC 120,651$1,134,1190.01%
Renaissance Technologies 271,712$2,554,0000.00%
View complete list of LUMOS PHARMA INC shareholders